Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
4.370
+0.120 (2.82%)
Nov 22, 2024, 4:00 PM EST - Market closed
Definitive Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 255.85 | 251.42 | 222.65 | 166.15 | 118.32 | 85.5 |
| Revenue Growth (YoY) | 3.97% | 12.92% | 34.00% | 40.43% | 38.38% | - |
| Cost of Revenue | 39.16 | 34.74 | 25.87 | 19.42 | 11.09 | 9.5 |
| Gross Profit | 216.68 | 216.68 | 196.79 | 146.73 | 107.23 | 76.01 |
| Selling, General & Admin | 144.37 | 153.4 | 141.15 | 89.25 | 48.7 | 37.2 |
| Research & Development | 39.11 | 42.44 | 34.89 | 18.57 | 11.06 | 7.45 |
| Operating Expenses | 235.01 | 247.59 | 232.94 | 167.76 | 119.34 | 78.18 |
| Operating Income | -18.33 | -30.91 | -36.15 | -21.03 | -12.11 | -2.18 |
| Interest Expense | -15.23 | -15.2 | -11.2 | -25.9 | -36.49 | -18.37 |
| Interest & Investment Income | 15.16 | 13.64 | 2.79 | 0.03 | - | - |
| Currency Exchange Gain (Loss) | -0.27 | - | - | - | -0.22 | - |
| Other Non Operating Income (Expenses) | 66.35 | 23.18 | 10.58 | 0.29 | - | - |
| EBT Excluding Unusual Items | 47.69 | -9.29 | -33.99 | -46.61 | -48.82 | -20.54 |
| Merger & Restructuring Charges | -14.15 | -11.19 | -6.64 | -2.52 | -1.14 | -15.85 |
| Impairment of Goodwill | -591.79 | -287.4 | - | - | - | - |
| Other Unusual Items | 2.94 | -0.3 | -1.25 | -13.64 | -2.64 | - |
| Pretax Income | -555.32 | -308.18 | -41.88 | -62.77 | -52.6 | -36.4 |
| Income Tax Expense | -35.23 | -18.55 | -17.7 | -0.44 | - | - |
| Earnings From Continuing Operations | -520.09 | -289.63 | -24.18 | -62.32 | -52.6 | -36.4 |
| Minority Interest in Earnings | 155.81 | 87.24 | 16.96 | 10.42 | - | - |
| Net Income | -364.28 | -202.39 | -7.22 | -51.91 | -52.6 | -36.4 |
| Preferred Dividends & Other Adjustments | - | - | - | -34.07 | -52.6 | - |
| Net Income to Common | -364.28 | -202.39 | -7.22 | -17.84 | - | -36.4 |
| Shares Outstanding (Basic) | 117 | 113 | 101 | 92 | 128 | 127 |
| Shares Outstanding (Diluted) | 117 | 113 | 101 | 92 | 128 | 127 |
| Shares Change (YoY) | 6.43% | 11.52% | 10.01% | -28.01% | 0.70% | - |
| EPS (Basic) | -3.11 | -1.79 | -0.07 | -0.19 | - | -0.29 |
| EPS (Diluted) | -3.11 | -1.79 | -0.07 | -0.19 | - | -0.29 |
| Free Cash Flow | 52.73 | 38.21 | 27.25 | 18.48 | 21.82 | 19.69 |
| Free Cash Flow Per Share | 0.45 | 0.34 | 0.27 | 0.20 | 0.17 | 0.16 |
| Gross Margin | 84.69% | 86.18% | 88.38% | 88.31% | 90.63% | 88.89% |
| Operating Margin | -7.16% | -12.29% | -16.24% | -12.66% | -10.24% | -2.54% |
| Profit Margin | -142.38% | -80.50% | -3.24% | -10.74% | - | -42.57% |
| Free Cash Flow Margin | 20.61% | 15.20% | 12.24% | 11.12% | 18.44% | 23.03% |
| EBITDA | 33.21 | 20.84 | 20.75 | 38.92 | 47.47 | 31.36 |
| EBITDA Margin | 12.98% | 8.29% | 9.32% | 23.42% | 40.12% | 36.68% |
| D&A For EBITDA | 51.54 | 51.75 | 56.9 | 59.95 | 59.58 | 33.54 |
| EBIT | -18.33 | -30.91 | -36.15 | -21.03 | -12.11 | -2.18 |
| EBIT Margin | -7.16% | -12.29% | -16.24% | -12.66% | -10.24% | -2.54% |
| Advertising Expenses | - | 1.6 | 1.6 | 0.9 | 0.6 | 0.4 |
Source: S&P Capital IQ. Standard template. Financial Sources.